PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Jun-2024 Formycon reports on the results of the Annual General Meeting Formycon AG
13-Jun-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
13-Jun-2024 DC Healthcare's Approve All Resolutions in AGM DC Healthcare
13-Jun-2024 Formycon starts clinical development program for FYB206, a biosimilar candidate for immuno-oncology blockbuster drug Keytruda Formycon AG
12-Jun-2024 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
12-Jun-2024 Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens Biophytis
12-Jun-2024 Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE
12-Jun-2024 Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering Siegfried AG
11-Jun-2024 M1 Kliniken announces change in the Management Board and confirms long-term growth strategy M1 Kliniken AG
11-Jun-2024 Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs Tacalyx GmbH
11-Jun-2024 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer Thermosome
11-Jun-2024 MPH Health Care AG: Q1-results 2024 MPH Health Care AG
11-Jun-2024 Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann Medartis Holding AG
10-Jun-2024 Evotec SE: Results of the Annual General Meeting 2024 Evotec SE
10-Jun-2024 Steve Nuckols Joins ArisGlobal as Chief Customer Officer ArisGlobal
10-Jun-2024 CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S CS MEDICA
10-Jun-2024 MEDICLIN: Annual General Meeting of MEDICLIN AG approves all proposed resolutions MEDICLIN AG
10-Jun-2024 Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity Biophytis
10-Jun-2024 DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024 Defence Therapeutics Inc.
07-Jun-2024 HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate... HighTide Therapeutics, Ltd.